Press Releases about Immunitybio IncFrom ImmunityBio, Inc.
Via Business Wire
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
From ImmunityBio, Inc.
Via Business Wire
From ImmunityBio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|